Title: 
Official Title: To amend the Public Health Service Act to direct the Secretary of Health and Human Services to develop a plan to improve the development and distribution of diagnostic tests during a public health emergency, and for other purposes.
Number of Sections: 3
Source: versions - Introduced in House
Media Type: text/xml

================================================================================

Section 1:
1.Short titleThis Act may be cited as the Diagnostics Testing Preparedness Plan Act of 2025.

Section 2:
2.Improving development and distribution of diagnostic testsSection 319B of the Public Health Service Act (42 U.S.C. 247d–2) is amended to read as follows:319B.Improving development and distribution of diagnostic tests(a)Diagnostic testing preparedness planThe Secretary shall develop, make publicly available, and update a plan for the rapid development, validation, authorization, manufacture, procurement, and distribution of diagnostic tests, and for rapid scaling of testing capacity, in response to chemical, biological, radiological, or nuclear threats, including emerging infectious diseases, for which a public health emergency is declared under section 319, or that has significant potential to cause such a public health emergency.(b)PurposesThe purpose of the plan under subsection (a) shall be to—(1)facilitate the development and utilization of diagnostic tests;(2)describe the processes for the rapid development, validation, authorization, manufacture, procurement, and distribution of diagnostic tests, and for rapid scaling of testing capacity; and(3)facilitate coordination and collaboration among public and private entities to improve the rapid development and utilization of diagnostic testing during a public health emergency.(c)ConsiderationsThe plan under subsection (a) shall take into consideration—(1)domestic capacity, including any such capacity established through partnerships with public and private entities pursuant to subsection (e), to support the development, validation, manufacture, procurement, and distribution of tests, and the rapid scaling of testing capacity;(2)novel technologies and platforms that—(A)may be used to improve testing capabilities, including—(i)high-throughput laboratory diagnostics;(ii)point-of-care diagnostics; and(iii)rapid at-home diagnostics;(B)improve the accessibility of diagnostic tests; and(C)facilitate the development and manufacture of diagnostic tests;(3)medical supply needs related to testing, including diagnostic testing, equipment, supplies, and component parts, and any potential vulnerabilities related to the availability of such medical supplies and related planning needs, consistent with section 2811(b)(4)(J);(4)strategies for the rapid and efficient distribution of tests locally, regionally, or nationwide and appropriate scaling of laboratory testing capacity; and(5)assessment of such strategies through drills and operational exercises carried out under section 2811(b)(4)(G), as appropriate.(d)CoordinationTo inform the development and update of the plan under subsection (a), and in carrying out activities to implement such plan, the Secretary shall coordinate with industry, such as device manufacturers, clinical and reference laboratories, and medical product distributors, States, local governmental entities, Indian Tribes and Tribal organizations, and other relevant public and private entities.(e)Capacity buildingThe Secretary may contract with public and private entities, as appropriate, to increase domestic capacity in the rapid development, validation, authorization, manufacture, procurement, and distribution of diagnostic tests, as appropriate, to State, local, and Tribal health departments and other appropriate entities for immediate public health response activities to address an infectious disease with respect to which a public health emergency is declared under section 319, or that has significant potential to cause such a public health emergency.(f)Deadlines for plan(1)Public releaseNot later than one year after the date of enactment of the Diagnostics Testing Preparedness Plan Act of 2025, the Secretary shall publicly release the plan developed under subsection (a).(2)UpdatesThe Secretary shall update such plan not less frequently than once every 3 years after the date of the initial public release of the plan..

Section 3:
319B.Improving development and distribution of diagnostic tests(a)Diagnostic testing preparedness planThe Secretary shall develop, make publicly available, and update a plan for the rapid development, validation, authorization, manufacture, procurement, and distribution of diagnostic tests, and for rapid scaling of testing capacity, in response to chemical, biological, radiological, or nuclear threats, including emerging infectious diseases, for which a public health emergency is declared under section 319, or that has significant potential to cause such a public health emergency.(b)PurposesThe purpose of the plan under subsection (a) shall be to—(1)facilitate the development and utilization of diagnostic tests;(2)describe the processes for the rapid development, validation, authorization, manufacture, procurement, and distribution of diagnostic tests, and for rapid scaling of testing capacity; and(3)facilitate coordination and collaboration among public and private entities to improve the rapid development and utilization of diagnostic testing during a public health emergency.(c)ConsiderationsThe plan under subsection (a) shall take into consideration—(1)domestic capacity, including any such capacity established through partnerships with public and private entities pursuant to subsection (e), to support the development, validation, manufacture, procurement, and distribution of tests, and the rapid scaling of testing capacity;(2)novel technologies and platforms that—(A)may be used to improve testing capabilities, including—(i)high-throughput laboratory diagnostics;(ii)point-of-care diagnostics; and(iii)rapid at-home diagnostics;(B)improve the accessibility of diagnostic tests; and(C)facilitate the development and manufacture of diagnostic tests;(3)medical supply needs related to testing, including diagnostic testing, equipment, supplies, and component parts, and any potential vulnerabilities related to the availability of such medical supplies and related planning needs, consistent with section 2811(b)(4)(J);(4)strategies for the rapid and efficient distribution of tests locally, regionally, or nationwide and appropriate scaling of laboratory testing capacity; and(5)assessment of such strategies through drills and operational exercises carried out under section 2811(b)(4)(G), as appropriate.(d)CoordinationTo inform the development and update of the plan under subsection (a), and in carrying out activities to implement such plan, the Secretary shall coordinate with industry, such as device manufacturers, clinical and reference laboratories, and medical product distributors, States, local governmental entities, Indian Tribes and Tribal organizations, and other relevant public and private entities.(e)Capacity buildingThe Secretary may contract with public and private entities, as appropriate, to increase domestic capacity in the rapid development, validation, authorization, manufacture, procurement, and distribution of diagnostic tests, as appropriate, to State, local, and Tribal health departments and other appropriate entities for immediate public health response activities to address an infectious disease with respect to which a public health emergency is declared under section 319, or that has significant potential to cause such a public health emergency.(f)Deadlines for plan(1)Public releaseNot later than one year after the date of enactment of the Diagnostics Testing Preparedness Plan Act of 2025, the Secretary shall publicly release the plan developed under subsection (a).(2)UpdatesThe Secretary shall update such plan not less frequently than once every 3 years after the date of the initial public release of the plan.


================================================================================

Raw Text:
119 HR 1108 IH: Diagnostics Testing Preparedness Plan Act of 2025
U.S. House of Representatives
2025-02-07
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



I119th CONGRESS1st SessionH. R. 1108IN THE HOUSE OF REPRESENTATIVESFebruary 7, 2025Mrs. Miller-Meeks (for herself, Ms. Schrier, Mr. Crenshaw, and Mr. Carson) introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo amend the Public Health Service Act to direct the Secretary of Health and Human Services to develop a plan to improve the development and distribution of diagnostic tests during a public health emergency, and for other purposes.1.Short titleThis Act may be cited as the Diagnostics Testing Preparedness Plan Act of 2025. 2.Improving development and distribution of diagnostic testsSection 319B of the Public Health Service Act (42 U.S.C. 247d–2) is amended to read as follows:319B.Improving development and distribution of diagnostic tests(a)Diagnostic testing preparedness planThe Secretary shall develop, make publicly available, and update a plan for the rapid development, validation, authorization, manufacture, procurement, and distribution of diagnostic tests, and for rapid scaling of testing capacity, in response to chemical, biological, radiological, or nuclear threats, including emerging infectious diseases, for which a public health emergency is declared under section 319, or that has significant potential to cause such a public health emergency.(b)PurposesThe purpose of the plan under subsection (a) shall be to—(1)facilitate the development and utilization of diagnostic tests;(2)describe the processes for the rapid development, validation, authorization, manufacture, procurement, and distribution of diagnostic tests, and for rapid scaling of testing capacity; and(3)facilitate coordination and collaboration among public and private entities to improve the rapid development and utilization of diagnostic testing during a public health emergency.(c)ConsiderationsThe plan under subsection (a) shall take into consideration—(1)domestic capacity, including any such capacity established through partnerships with public and private entities pursuant to subsection (e), to support the development, validation, manufacture, procurement, and distribution of tests, and the rapid scaling of testing capacity;(2)novel technologies and platforms that—(A)may be used to improve testing capabilities, including—(i)high-throughput laboratory diagnostics;(ii)point-of-care diagnostics; and(iii)rapid at-home diagnostics;(B)improve the accessibility of diagnostic tests; and(C)facilitate the development and manufacture of diagnostic tests;(3)medical supply needs related to testing, including diagnostic testing, equipment, supplies, and component parts, and any potential vulnerabilities related to the availability of such medical supplies and related planning needs, consistent with section 2811(b)(4)(J);(4)strategies for the rapid and efficient distribution of tests locally, regionally, or nationwide and appropriate scaling of laboratory testing capacity; and(5)assessment of such strategies through drills and operational exercises carried out under section 2811(b)(4)(G), as appropriate.(d)CoordinationTo inform the development and update of the plan under subsection (a), and in carrying out activities to implement such plan, the Secretary shall coordinate with industry, such as device manufacturers, clinical and reference laboratories, and medical product distributors, States, local governmental entities, Indian Tribes and Tribal organizations, and other relevant public and private entities.(e)Capacity buildingThe Secretary may contract with public and private entities, as appropriate, to increase domestic capacity in the rapid development, validation, authorization, manufacture, procurement, and distribution of diagnostic tests, as appropriate, to State, local, and Tribal health departments and other appropriate entities for immediate public health response activities to address an infectious disease with respect to which a public health emergency is declared under section 319, or that has significant potential to cause such a public health emergency.(f)Deadlines for plan(1)Public releaseNot later than one year after the date of enactment of the Diagnostics Testing Preparedness Plan Act of 2025, the Secretary shall publicly release the plan developed under subsection (a).(2)UpdatesThe Secretary shall update such plan not less frequently than once every 3 years after the date of the initial public release of the plan..